
4.18 Delayed Data As of May 23 | ![]() Today’s Change | 2.49 Today|||52-Week Range 5.53 | -4.46% Year-to-Date |
Previous close | 3.68 |
Today’s open | 3.73 |
Day’s range | 3.57 - 4.77 |
Volume | 25,427,103 |
Average volume (3 months) | 3,652,821 |
Market cap | $929.4M |
Earnings growth (last year) | -26.24% |
Earnings growth (this year) | +14.21% |
Earnings growth (next 5 years) | +30.20% |
Revenue growth (last year) | +15.81% |
P/E ratio | NM |
Price/Sales | 14.44 |
Price/Book | -- |
---- | ||
ENTAEnanta Pharmaceutica... | +0.60 | +1.43% |
RVNCRevance Therapeutics... | -0.60 | -4.36% |
KURAKura Oncology Inc | +0.16 | +1.27% |
Next reporting date | August 10, 2022 |
EPS forecast (this quarter) | -$0.09 |
Annual revenue (last year) | $75.4M |
Annual profit (last year) | -$80.9M |
Net profit margin | -107.27% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Danbury, Connecticut |